Literature DB >> 5008339

Brain amine concentrations after monoamine oxidase inhibitor administration.

A B Jones, C M Pare, W J Nicholson, K Price, R S Stacey.   

Abstract

The concentrations of 5-hydroxytryptamine (5HT), noradrenaline, and dopamine were estimated post mortem in brain stem, hypothalamus, and caudate nucleus in 33 patients who had been treated with isocarboxazid, clorgyline, or tranylcypromine and 11 controls. Similar and highly significant increases in 5HT and noradrenaline concentration occurred with all three drugs. The distribution was unimodal, but about a quarter of the patients showed only a small increase in brain amines. Tranylcypromine seemed to have a significantly greater effect on dopamine in caudate nucleus and hypothalamus compared with isocarboxazid and clorgyline. In the doses used chlorpromazine did not reduce the amine concentrations. Four patients with Parkinson's syndrome had low concentrations of dopamine in caudate nucleus in spite of monoamine oxidase inhibitor administration.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5008339      PMCID: PMC1789129          DOI: 10.1136/bmj.1.5791.17

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  16 in total

1.  A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations.

Authors:  J ANGST
Journal:  Psychopharmacologia       Date:  1961-12-19

2.  Mono-amine oxidase inhibitors, sleep and mood.

Authors:  M O Akindele; J I Evans; I Oswald
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1970-07

3.  5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

Authors:  C M Pare; D P Yeung; K Price; R S Stacey
Journal:  Lancet       Date:  1969-07-19       Impact factor: 79.321

4.  Multiple forms of human brain mitochondrial monoamine oxidase.

Authors:  G G Collins; M Sandler; E D Williams; M B Youdim
Journal:  Nature       Date:  1970-02-28       Impact factor: 49.962

5.  Effect of thyroid hormone on the biochemical maturation of rat brain: conversion of glucose-carbon into amino acids.

Authors:  J A Cocks; R Balázs; A L Johnson; J T Eayrs
Journal:  J Neurochem       Date:  1970-08       Impact factor: 5.372

6.  Further studies on the inhibition of monoamine oxidase by M and B 9302 (clorgyline). I. Substrate specificity in various mammalian species.

Authors:  D W Hall; B W Logan; G H Parsons
Journal:  Biochem Pharmacol       Date:  1969-06       Impact factor: 5.858

7.  Multiple forms of rat brain monoamine oxidase.

Authors:  M B Youdim; G G Collins; M Sandler
Journal:  Nature       Date:  1969-08-09       Impact factor: 49.962

8.  Effect of L-dopa on brain monoamines and their metabolites in Parkinson's disease.

Authors:  U K Rinne; V Sonninen; M Hyyppä
Journal:  Life Sci I       Date:  1971-05-15

9.  Intramuscular nialamide in depressed patients (a biochemical study).

Authors:  C M Pare; G C Jenner
Journal:  Dis Nerv Syst       Date:  1966-03

10.  Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.

Authors:  B Alexanderson; D A Evans; F Sjöqvist
Journal:  Br Med J       Date:  1969-12-27
View more
  6 in total

1.  New horizons in psychopharmacology.

Authors:  W Linford
Journal:  Proc R Soc Med       Date:  1972-09

2.  Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers.

Authors:  A Moretti; C Caccia; A Martini; L Bonollo; A Amico; R Sega; V Nicolella; F B Nicolis
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

3.  Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.

Authors:  M K Lakshmana; B S Rao; N K Dhingra; R Ravikumar; S Sudha; B L Meti; T R Raju
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

Review 4.  Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition.

Authors:  M B Youdim; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 5.  Platelet monoamine oxidase B: use and misuse.

Authors:  M B Youdim
Journal:  Experientia       Date:  1988-02-15

Review 6.  Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases.

Authors:  Moussa B H Youdim
Journal:  J Neural Transm (Vienna)       Date:  2018-10-19       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.